title: Melatonin protects against oxidative organ injury in a rat model of sepsis.
abstract: OBJECTIVE
  Based on the potent antioxidant effects of melatonin, we investigated the putative protective role of melatonin against sepsis-induced oxidative organ damage in rats.
  
  
  METHODS
  Sepsis was induced by cecal ligation and puncture (CLP) in Wistar albino rats. Animals subjected to CLP and sham-operated control rats were given saline or melatonin 10 mg/kg intraperitoneally 30 min before and 6 h after the operation. The rats were killed 16 h after the operation and the biochemical changes were investigated in the liver, kidney, heart, lung, diaphragm, and brain tissues by examining malondialdehyde (MDA) and glutathione (GSH) levels, and myeloperoxidase (MPO) activity. We also examined the tissues microscopically.
  
  
  RESULTS
  Sepsis resulted in a significant decrease in GSH levels and a significant increase in MDA levels and MPO activity (P < 0.05-P < 0.001) showing oxidative damage, which was confirmed by histological examination. Melatonin clearly reversed these oxidant responses and the microscopic damage, demonstrating its protective effects against sepsis-induced oxidative organ injury.
  
  
  CONCLUSIONS
  The increase in MDA levels and MPO activity and the concomitant decrease in GSH levels demonstrate the role of oxidative mechanisms in sepsis-induced tissue damage. Melatonin, by its free radical scavenging and antioxidant properties, ameliorated oxidative organ injury. Thus, supplementing antiseptic shock treatment with melatonin may be beneficial in the clinical setting.
authors.affiliation: Department of Pharmacology, School of Pharmacy, Marmara University, Haydarpaşa, Istanbul, 34668, Turkey.
authors.forename: Göksel
authors.initials: G
authors.lastname: Sener
authors.forename: Hale
authors.initials: H
authors.lastname: Toklu
authors.forename: Caner
authors.initials: C
authors.lastname: Kapucu
authors.forename: Feriha
authors.initials: F
authors.lastname: Ercan
authors.forename: Gözde
authors.initials: G
authors.lastname: Erkanli
authors.forename: Ayhan
authors.initials: A
authors.lastname: Kaçmaz
authors.forename: Metin
authors.initials: M
authors.lastname: Tilki
authors.forename: Berrak C
authors.initials: BC
authors.lastname: Yeğen
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005978:Glutathione / Q000032:analysis*; D008111:Liver Function Tests; D008297:Male; D008315:Malondialdehyde / Q000032:analysis*; D008550:Melatonin / Q000494:pharmacology*; D009102:Multiple Organ Failure / Q000517:prevention & control*; D010084:Oxidation-Reduction / Q000187:drug effects; D011336:Probability; D051381:Rats; D017208:Rats, Wistar; D012680:Sensitivity and Specificity; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality*; D015996:Survival Rate
chemical_list: D008315:Malondialdehyde; D005978:Glutathione; D008550:Melatonin